Developmental expression of cytochrome P450 enzymes in human liver

Pharmacology and Toxicology

Volumn 82, Issue 5, 1998, Pages 209-217

  Hakkola, Jukka ^a   Tanaka, Einosuke ^b   Pelkonen, Olavi ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; DEBRISOQUINE 4 HYDROXYLASE; DIMETHYLNITROSAMINE DEMETHYLASE; ETHOXYRESORUFIN DEETHYLASE; PENTOXYRESORUFIN DEALKYLASE; PHENACETIN O DEETHYLASE;

DEVELOPMENT; HUMAN; LIVER; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; TRANSCRIPTION REGULATION;

EID: 0031810509     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1998.tb01427.x     Document Type: Short Survey

References (84)

1. Aranda, J. V., W. Gorman, H. Bergteinsson & T. Gunn: Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J. Pediatr. 1977, 90, 467-472.
2. Boreus, L. O.: The role of therapeutic drug monitoring in children. Clin. Pharmacokinet. 1989, 17 (suppl. 1), 4-12.
3. PA (P-450IA2), the phenacetin O-deetylase, is primarily reponsible for hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. USA. 1989, 86, 7696-7700.
4. Carpenter, S. J., J. M. Lasker & J. L. Raucy: Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human foetal liver and hepatocytes. Mol. Pharmacol. 1996, 49, 260-268.
5. Carrier, O., G. Pons, E. Rey, M.-O. Richard, C. Moran, J. Badoual & G. Olive: Maturation of caffeine metabolic pathways in infancy. Clin. Pharmacol. Therap. 1988, 44, 145-151.
6. Cazeneuve, C., G. Pons, E. Rey, J.-M. Treluyer, T. Cresteil, G. Thiroux, P. D'athis & G. Olive: Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults. Brit. J. Clin. Pharmacol. 1994, 37, 405-412.
7. Cresteil, T., P. Beaune, P. Kremers, C. Celier, F. P. Guengerich & J. P. Leroux: Immunoquantification of epoxide hydroxylase and cytochrome P-450 isozymes in foetal and adult human liver microsomes. Eur. J. Biochem. 1985, 151, 345-350.
8. Crom, W. R., M. V. Relling, M. L. Christensen, G. K. Rivera & W. E. Evans: Age-related differences in hepatic drug clearences in children: studies with lorazepam and antipyrine. Clin. Pharmacol. Therap. 1991, 50, 132-140.
9. Crom, W. R.: Pharmacokinetics in the child. Environ. Health Perspect. 1994, 102 (suppl. 11), 111-118.
10. Daly, A.K., J. Brockmöller, F. Broly, M. Eichelbaum, W. E. Evans, F. J. Gonzalez, J.-D. Huang, J. R. Idle, M. Ingelman-Sundberg, T. Ishizaki, E. Jacqz-Aigrain, U. A. Meyer, D. W. Nebert, V. M. Steen, C. R. Wolf & U. M. Zanger: Nomenclature for human CYP2D6 alleles. Pharmacogenetics 1996, 6, 193-201.
11. Denison, M. S. & J. P. J. Whitlock: Xenobiotic-inducible transcription of cytochrome P450 genes. J. Biol. Chem. 1995, 270, 18175-18178.
12. Ding, S., B. G. Lake, T. Friedberg & C. R. Wolf: Expression and alternative splicing of the cytochrome P-450 CYP2A7. Biochem. J. 1995, 306, 161-166.
13. Evans, W. E., M. V. Relling, S. de Graaf, J. H. Rodman, J. A. Pieper, M. L. Christensen & W. R. Crom: Hepatic drug clearance in children: studies with indocyanine green as a model substrate. J. Pharm. Sci. 1989, 78, 452-456.
14. Fernandez-Salguero, R., S. M. G. Hoffman, S. Cholerton, H. Mohrenweiser, H. Raunio, A. Rautio, O. Pelkonen, J. Huang, W. E. Evans, J. R. Idle & F. J. Gonzalez: A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Amer. J. Hum. Genet. 1995, 57, 651-660.
15. Fisher, D. M., C. O'Keeffe, D. R. Stanski, R. Cronnelly, R. D. Miller & G. A. Gregory: Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults. Anesthesiology 1982, 57, 203-208.
16. Frederiksen, M. C., T. I. Ruo, M. J. Chow & A. J. Atkinson: Theophylline pharmacokinetics in pregnancy. Clin. Pharmacol. Therap. 1986, 40, 321-328.
17. Goldstein, J. A. & S. M. F. de Morais: Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 1994, 4, 285-299.
18. Gonzalez, F. J.: Control of constitutively-expressed developmentally-activated rat hepatic cytochrome genes. Keio J. Med. 1992, 41, 68-75.
19. Gonzalez, F. J. & Y.-H. Lee: Constitutive expression of hepatic cytochrome P450 genes. FASEB J. 1996, 10, 1112-1117.
20. Greuet, J., L. Pichard, C. Bonfils, J. Domergue & P. Maurel: The foetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture. Biochem. Biophys. Res. Commun. 1996, 225, 689-694.
21. Guengerich, F. P.: Cytochromes P450 of human liver. Classification and activity profiles of the major enzymes. In: Advances in drug metabolism in man. Eds.: G. M. Pacifici & G. N. Fracchia. European Commission. Office for the Official Publications of the European Communities, Luxembourg, 1995, 179-231.
22. Hakkola, J., M. Pasanen, R. Purkunen, S. Saarikoski, O. Pelkonen, J. Mäenpää, A. Rane & H. Raunio: Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and foetal liver. Biochem. Pharmacol. 1994, 48, 59-64.
23. Hakkola, J., M. Pasanen, O. Pelkonen, J. Hukkanen, S. Evisalmi, S. Anttila, A. Rane, M. Mäntylä, R. Purkunen, S. Saarikoski, M. Tooming & H. Raunio: Expression of CYP1B1 in human adult and foetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis 1997, 18, 391-397.
24. Imaoka, S., T. Yamada, T. Hiroi, K. Hayashi, T. Sakaki, Y. Yabusaki & Y. Funae: Multiple forms of human P450 expressed in Saccharomyces cerevisiae, systematic characterization and comparison with those of the rat. Biochem. Pharmacol. 1996, 51, 1041-1050.
25. Ingelman-Sundberg, M.: Ethanol-inducible cytochrome P450 2E1. Regulation, radical formation and toxicological importance. In: Free radicals: From basic science to medicine. Eds.: G. Poli, E. Albano & M. U. Dianzani Birkhäuser Verlag, Basel, 1993, 287-301.
26. Ingelman-Sundberg, M. & I. Johansson: The molecular genetics of the human drug metabolizing cytochrome P450s. In: Advances in drug metabolism in man. Eds.: G. M. Pacifici & G. N. Fracchia. Office for Official Publications of the European Communities, Luxemburg, 1995, 534-585.
27. Ioannides, C. & D. V. Parke: Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis. Drug Metab. Rev. 1993, 25, 485-501.
28. Jarboe, C. H., H. E. Hurst, G. C. Rodgers & J. M. Metataxas: Toxicokinetics of caffeine elimination in an infant. Clin. Toxicol. 1986, 24, 415-428.
29. Jones, S. M., A. R. Boobis, G. E. Moore & P. M. Stanier: Expression of CYP2E1 during human foetal development: methylation of the CYP2E1 gene in human foetal and adult liver samples. Biochem. Pharmacol. 1992, 43, 1876-1879.
30. Jounaidi, Y., V. Hyrailles, L. Gervot & P. Maurel: Detection of CYP3A5 allelic variant: a candidate for the polymorphic expression of the protein? Biochem. Biophys. Res. Commun. 1996, 221, 466-470.
31. Kearns, G. L. & M. D. Reed: Clinical pharmacokinetics in infants and children. Clin. Pharmacokinet. 1989, 17 (suppl. 1), 29-67.
32. Kitada, M., T. Kamataki, K. Itahashi, T. Rikihisa, R. Kato & Y. Kanakubo: Purification and properties of cytochrome P-450 from homogenates of human foetal livers. Arch. Biochem. Biophys. 1985, 241, 275-280.
33. Kitada, M., T. Kamataki, K. Itahashi, T. Rikihisa & Y. Kanakubo: Significance of cytochrome P-450 (P-450 HFLa) of human foetal livers in the steroid and drug oxidations. Biochem. Pharmacol. 1987a, 36, 453-456.
34. Kitada, M., T. Kamataki, K. Itahashi, T. Rikihisa & Y. Kanakubo: P-450 HFLa, a form of cytochrome P-450 purified from human foetal livers, is the 16α-hydroxylase of dehydroepiandrosterone 3-sulfate. J. Biol. Chem. 1987b, 262, 13534-13537.
35. Kitada, M., M. Taneda, K. Itahashi & T. Kamataki: Four forms of cytochrome P-450 in human foetal livers: purification and their capacity to activate promutagens. Jap. J. Cancer Res. 1991, 82, 426-432.
36. Kitada, M. & T. Kamataki: Cytochrome P450 in human foetal liver: significance and foetal specific expression. Drug Metab. Rev. 1994, 26, 305-323.
37. Kitamura, R., K. Sato, M. Sawada, S. Itoh, M. Kitada, M. Komori & T. Kamataki: Stable expression of cytochrome P450IIIA7 cDNA in human breast cancar cell line MCF-7 and its application to cytotoxicity testing. Arch. Biochem. Biophys. 1992, 292, 136-140.
38. Klinger, W.: Biotransformation of drugs and other xenobiotics during postnatal development. Exp. Toxic. Pathol. 1996, 48 (suppl. 1), 1-88.
39. Komori, M., K. Nishio, T. Fujitani, H. Ohi, M. Kitada, S. Mima, K. Itahashi & T. Kamataki: Isolation of a new human foetal liver cytochrome P450 cDNA clone: evidence for expression of a limited number of forms of cytochrome P450 in human foetal livers. Arch. Biochem. Biophys. 1989a, 272, 219-225.
40. Komori, M., K. Nishio, H. Ohi, M. Kitada & T. Kamataki: Molecular cloning and sequence analysis of cDNA containing the entire coding region for human foetal liver cytochrome P-450. J. Biochem. 1989b, 105, 161-163.
41. Komori, M., K. Nishio, M. Kitada, K. Shiramatsu, K. Muroya, M. Soma, K. Nagashima & T. Kamataki: Fetus-specific expression of a form of cytochrome P-450 in human livers. Biochemistry 1990, 29, 4430-4433.
42. Koop, D. R.: Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J. 1992, 6, 724-730.
43. Ladona, M. G., B. Lindström, C. Thyr, P. Dun-Ren & A. Rane: Differential foetal development of the O- and N-demethylation of codeine and dextromethorphan in man. Brit. J. Clin. Pharmacol. 1991, 32, 295-302.
44. Li, Y., T. Yokoi, R. Kitamura, M. Sasaki, M. Gunji, M. Katsuki & T. Kamataki: Establishment of transgenic mice carrying human fetus-specific CYP3A7. Arch. Biochem. Biophys. 1996, 329, 235-240.
45. Mäenpää, J., A. Rane, H. Raunio, P. Honkakoski & O. Pelkonen: Cytochrome P450 isoforms in human foetal tissues related to phenobarbital-inducible forms in the mouse. Biochem. Pharmacol. 1993, 45, 899-907.
46. McKinnon, R. A., P. M. Hall, L. C. Quattrochi, R. H. Tukey & M. E. McManus: Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridization. Hepatology, 1991, 14, 848-856.
47. Milsap, R. L. & W. J. Jusko: Pharmacokinetics in the infant. Environ. Health Perspect. 1994, 102 (suppl. 11), 107-110.
48. Morselli, P. L.: Clinical pharmacology of perinatal period and early infancy. Clin. Pharmacokin. 1989, 17 (suppl. 1), 13-28.
49. Murray, G. I., C. O. Foster, T. S. Barnes, R. J. Weaver, C. P. Snyder, S. W. B. Ewen, W. T. Melvin & M. D. Burke: Cytochrome P450IA expression in adult and foetal human liver. Carcinogenesis 1992, 13, 165-169.
50. Nelson, D. R., L. Koymans, T. Kamataki, J. J. Stegeman, R. Feyereisen, D. J. Waxman, M. R. Waterman, O. Gotoh, M. J. Coon, R. W. Estabrook, I. C. Gunsalus & D. W. Nebert: P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996, 6, 1-42.
51. Omiecinski, C. J., C. A. Redlich & P. Costa: Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues. Cancer Res. 1990, 50, 4315-4321.
52. Pasanen, M., O. Pelkonen, A. Kauppila, S. S. Park, F. K. Friedman & H. V. Gelboin: Characterization of human foetal hepatic cytochrome P-450-associated 7-ethoxyresorufin O-deethylase and aryl hydrocarbon hydroxylase activities by monoclonal antibodies. Dev. Pharmacol. Therap. 1987, 10, 125-132.
53. Pelkonen, O.: Biotransformation of xenobiotics in the fetus. Pharmacol. Therap. 1980, 10, 261-281.
54. Pelkonen, O., H. Raunio, A. Rautio, J. Mäenpää & M. A. Lang: Coumarin 7-hydroxylase: characteristics and regulation in mouse and man. J. Irish Coll. Phys. Surg. 1993, 22, 24-28.
55. Pelkonen, O., H. Raunio, A. Rautio, M. Pasanen & M. A. Lang: The metabolism of coumarin. In: Coumarins: biology, applications and mode of action. Eds:. R. O'Kennedy & R. D. Thornes John Wiley & Sons Ltd., 1997, 67-92.
56. 2 breath test. Pediatr. Res. 1988, 23, 632-636.
57. Rane, A., S. Henningson, B. Ask & M. G. Ladona: Comparison of human foetal hepatic and adrenal cytochrome P450 activities with some major gestational steroids and ethylmorphine as substrates. J. Steroid Biochem. Molec. Biol. 1992, 43, 335-341.
58. Ratanasavanh, D., P. Beaune, F. Morel, J.-P. Flinois, F. P. Guengerich & A. Guillouzo: Intralobular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age. Hepatology 1991, 13, 1142-1151.
59. Raucy, J. L. & S. J. Carpenter: The expression of xenobiotic-metabolizing cytochromes P450 in foetal tissues. J. Pharmacol. Toxicol. Meth. 1993, 29, 121-128.
60. Roberts, B. J., B.-J. Song, Y. Soh, S. S. Park & S. E. Shoaf: Ethanol induces CYP2E1 by protein stabilization. J. Biol. Chem. 1995, 270, 29632-29635.
61. Sakuma, T., R. Kitamura, T. Yokoi & T. Kamataki: Efficient complementary DNA directed expression of human foetal liver cytochrome P450 (CYP3A7) in insect cells using baculovirus. Arch. Biochem. Biophys. 1995, 11520, 22828-4654.
62. Schuetz, J. D., D. L. Beach & P. S. Guzelian: Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 1994, 4, 11-20.
63. Shimada, T., K. S. Misono & F. P. Guengerich: Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 1986, 261, 909-921.
64. Shimada, T., H. Yamazaki, M. Mimura, Y. Inui & F. P. Guengerich: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Therap. 1994, 270, 414-423.
65. Shimada, T., C. L. Hayes, H. Yamazaki, S. Amin, S. S. Hecht, F. P. Guengerich & T. R. Sutter: Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 1996a, 56, 2979-2984.
66. Shimada, T., H. Yamazaki, M. Mimura, N. Wakamiya, Y.-F. Ueng, F. P. Guengerich & Y. Inui: Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human foetal livers and adult lungs. Drug Metab. Dispos. 1996b, 24, 515-522.
67. Thomson, A. H., S. Kerr & S. Wright: Population pharmacokinetics of caffeine in neonates and young infants. Ther. Drug Monit. 1996, 18, 245-253.
68. Treluyer, J.-M., E. Jacqz-Aigrain, F. Alvarez & T. Cresteil: Expression of CYP2D6 in developing human liver. Eur. J. Biochem. 1991, 202, 583-588.
69. Treluyer, J. M., G. Cheron, M. Sonnier & T. Cresteil: Cytochrome P-450 expression in sudden infant death syndrome. Biochem. Pharmacol. 1996, 52, 497-504.
70. Umberhauer, D. R., M. V. Martin, R. S. Lloyd & F. P. Guengerich: Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase. Biochemistry 1987, 26, 1094-1099.
71. Umeno, M., B. J. Song, C. Kozak, H. V. Gelboin & F. J. Gonzalez: The rat P450 IIE1 gene: complete intron and exon sequence, chromosome mapping and correlation of developmetal expression with specific 5′ cytosme demethylation. J. Biol. Chem. 1988, 263, 4956-4962.
72. Vauzelle-Kervroedan, F., E. Rey, A. Pariente-Khayat, T. Bienvenu, J. Badoual, G. Olive & G. Pons: Non invasive in vivo study of the maturation of CYP IIIA in neonates and infants. Eur. J. Clin. Pharmacol. 1996, 51, 69-72.
73. Vieira, I., M. Sonnier & T. Cresteil: Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur. J. Biochem. 1996, 238, 476-483.
74. Wiebkin, P., J. H. Dees, J. M. Mathis & R. A. Prough: Drug metabolism by isolated foetal human hepatocytes in suspension and primary culture. Drug Metab. Disp. 1985, 13, 163-168.
75. Wrighton, S. A., D. T. Molowa & P. S. Guzelian: Identification of a cytochrome P-450 in human foetal liver related to glucocorticoid-inducible cytochrome P-450HLp in the adult. Biochem. Pharmacol. 1988, 37, 3053-3055.
76. Wrighton, S. A., B. J. Ring, P. B. Watkins & M. VandenBranden: Identification of a polymorphically expressed member of the human cytochrome P-450III family. Mol. Pharmacol. 1989, 86, 97-105.
77. Wrighton, S. A., W. R. Brian, M. A. Sari, M. Iwasaki, F. P. Guengerich, J. L. Raucy, D. T. Molowa & M. VandenBranden: Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol. Pharmacol. 1990, 38, 207-213.
78. Wrighton, S. A. & J. C. Stevens: The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 1992, 22, 1-21.
79. Wrighton, S. A. & M. VandenBranden: Isolation and characterization of human foetal liver cytochrome P450HLp2: a third member of the P450III gene family. Arch. Biochem. Biophys. 1989, 268, 144-151.
80. Wu, D. & A. I. Cederbaum: Expression of cytochrome P4502E1 in rat foetal hepatocyte culture. Mol. Pharmacol. 1996, 49, 802-807.
81. Yamano, S., P. T. Nhamburo, T. Aoyama, U. A. Meyer, T. Inaba, W. Kalow, H. V. Gelboin, O. W. McBride & F. J. Gonzalez: cDNA cloning and sequence and cDNA-direcled expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and different expression of the IIB mRNAs in human liver. Biochemistry 1989, 28, 7340-7348.
82. Yamazaki, H., Y. Inui, S. A. Wrighton, F. P. Guengerich & T. Shimada: Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes. Carcinogenesis 1995, 16, 2167-2170.
83. Yang, H.-Y. L., Q. P. Lee, A. E. Rettie & M. R. Juchau: Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis. Mol. Pharmacol. 1994, 46, 922-928.
84. Yang, H.-Y. L., M. J. Namkung & M. R. Juchau: Expression of functional cytochrome P4501A1 in human embryonic hepatic tissues during organogenesis. Biochem. Pharmacol. 1995, 49, 717-726.